financetom
Business
financetom
/
Business
/
Microsoft's AI Market Position, Azure Growth Boost Investor Confidence, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft's AI Market Position, Azure Growth Boost Investor Confidence, UBS Says
Jul 26, 2024 10:09 AM

12:41 PM EDT, 07/26/2024 (MT Newswires) -- Microsoft ( MSFT ) holds a strong position in the artificial intelligence infrastructure market with a promising growth trajectory for Azure backed by significant contributions from AI and non-AI sectors, UBS Securities said in an earnings preview emailed Friday.

CoreWeave's revenue and backlog growth, coupled with OpenAI's substantial investment in Azure makes these growth estimates seem attainable and reinforces investor confidence, according to the firm.

UBS said it is raising fiscal 2025 capex estimates to $73 billion from $68 billion to underscore Microsoft's ( MSFT ) commitment to expanding its AI and cloud capabilities.

The firm said Office 365's growth may be tempered by slower seat expansion, but the potential impact of Copilot could "offer an upside surprise" by December.

Microsoft's ( MSFT ) stock is down 10% since early July despite typically bullish sentiments as hedge funds are adopting a neutral or short stance due to minimal perceived upside, UBS added.

The firm reiterated its buy rating on Microsoft's ( MSFT ) stock and kept the price target at $520.

Price: 426.23, Change: +7.83, Percent Change: +1.87

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved